This cohort study found that key sociodemographic, health care, and clinical factors are associated with receipt of semaglutide, a novel glucagon-like peptide-1 (GLP-1) receptor agonist medication, in ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

This cohort study found that key sociodemographic, health care, and clinical factors are associated with receipt of semaglutide, a ...

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity ...

Lipidated analogues of glucagon-like peptide 1 (GLP-1) have gained enormous attention ... This work provides a systematic study of the solubility, structure, oligomerization, and long-term stability ...

Drugs targeting the glucagon-like peptide-1 receptor (GLP-1R ... three smaller biotechs - Viking Therapeutics, Altimmune, and Structure Therapeutics - are emerging as potential disrupters in ...

This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing ...

AAV is a virus with low immunogenicity and a simple structure, used for delivering ... as various bioactive substances, with glucagon-like peptide (GLP)-1 being a representative example.

Two weeks into the job, it’s clear that newly elected State Treasurer Brad Briner won’t shy away from taking action, even if ...

Take glucagon-like peptide-1 receptor agonists (GLP-1s ... DiMarchi and his colleagues changed the structure of insulin to make it work better around mealtime for insulin-dependent diabetics.

Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding demand has caused many to wonder if they are indeed the magical solution to ...